NIST Now "King of the Hill" on Cyber Standards
Client Alert | 1 min read | 05.14.13
Following its key cyber role in President Obama's Executive Order No. 13636 issued this February, the National Institute of Standards and Technology (NIST) again seized the reins on federal cybersecurity standards on April 30, issuing the 457-page tome, Security and Privacy Controls for Federal information Systems and Organizations, that not only provides the "most comprehensive update" of the core information security controls, but also cuts new ground for cybersecurity standards governing mobile and cloud computing technology, applications security, supply chain protection, advanced persistent threats, and privacy controls for federal agencies and contractors. While some critics have sought to brush back prior NIST standards as too voluminous and technically dense, this latest publication underscores NIST's increasing dominance over cyber standards, as shown by both DoD and the Office of the Director of National Intelligence embracing this NIST update, thus paving the way for federal agencies to flow down new and expanded security standards to government contractors consistent with the executive order's directive to the FAR Council.
Contacts
Insights
Client Alert | 7 min read | 09.14.26
AI in Life Sciences: Ten Legal Considerations and Risks of AI Use in Drug Discovery and Development
Over the past several years, the biopharmaceutical industry has embraced artificial intelligence and machine learning (AI/ML) in near lockstep with the pace of AI/ML innovations. Today, industry leaders are using AI/ML to, among other things: discover and assess biological pathways, target chemical structures and sequences; design proteins; model pre-clinical and clinical trials; recruit and screen potential patient populations; evaluate clinical trial results and biomarker data; prepare regulatory filings; and manage supply chains. Deployment of new AI/ML models promises extraordinary advances in pharmaceutical development. However, as with any technological and scientific advances, the use of AI/ML also poses substantial legal risks that life sciences companies need to consider and proactively manage.
Client Alert | 6 min read | 09.11.26
It’s LIVE: The Cyber Resilience Act Reporting Is Mandatory as of Today - 11 September 2026
Client Alert | 10 min read | 09.11.26
Mining, Indigenous Consultation Rights, and Investment Treaty Protection
Client Alert | 2 min read | 09.11.26
New ISOO Guidance Directs Federal Agencies to Provide More CUI Guidance to Contractors

